We are monitoring the impact of COVID-19 on North America Veterinary/Animal Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 61
Share on
Share on

North America Animal / Veterinary Vaccines Market Research Report – Segmented By Type, Technology and Country (The U.S., Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 61
Pages: 134

North American Animal / Veterinary Vaccines Market (2021 to 2026)

The North America Animal / Veterinary Vaccines Market is estimated to be worth USD 2.68 Billion by 2026 from USD 2.11 Billion in 2021, growing at a CAGR of 4.93% from 2021 to 2026.

The primary goals of veterinary vaccines are to improve the health of companion animals, cost-effectively increase livestock production, and prevent zoonotic disease transmission from both domestic and wild animals. The veterinary vaccine market in the North American region has shown significant growth in recent years, attributed to increasing husbandry practices and better managing farms. Furthermore, it marks the estimation of further growth in the market due to the advancement in biotechnological research.

The North America Animal / Veterinary Vaccines Market has undergone considerable progress during the past few years. The growing usage of continuous cell lines as a substrate and embracing the fermentor technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics. But it should be kept in mind that USDA APHIS regulations must be stringently followed for approval and distribution of veterinary biologics across the USA, the dominant economy in this region.

An increase in animal-borne diseases and awareness about veterinary healthcare is the primary factor in increasing the animal vaccine market growth globally. The number of pet owners worldwide, especially in North America, has gone up, predicted to help the market gain speed. Increasing investments by leading market players, various government agencies and animal associations, continuous innovations, and raising awareness against antimicrobials drive the vaccine producers to invest significantly in developing new products.

The Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans, increasing investments by leading players, various government agencies, and animal associations; continuous innovations, raising awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into the development of new products.

However, rising maintenance costs for the storage of vaccines and increasing adoption of a vegetarian diet in major economies due to the increased risk of obesity and other chronic diseases are key restraints.

Impact of COVID-19 on the North American veterinary vaccines market:

COVID-19 has disrupted the supply chain of products all over the world. The risk of disease transmission from animals to humans has come to light in the last few months owing to the worldwide spread of COVID-19. Individuals and governments are expected to focus on domestic and wild animals' health in the future, thus increasing the market.

This research report on the North American veterinary vaccines market has been segmented and sub-segmented into the following categories:

By Type: 

  • Livestock Vaccines
    • Bovine
    • Porcine
    • Ovine
    • Poultry
    • Equine  
  • Companion Vaccines
    • Feline Vaccines
    • Canine Vaccines

By Technology: 

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Conjugate Vaccines

Based on technology, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment due to the higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine.

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Geographically, in North America, the U.S. veterinary vaccines market is forecasted to account for the most significant share from 2021 to 2026, owing to the rapid adoption of technological advancements. In addition, ongoing research on developing innovative drugs and vaccines with modern techniques promotes the market's growth rate in the United States.

The Canadian Veterinary Vaccines Market is estimated to have a promising CAGR during the forecast period. Rising concern towards animal health and shifting trends towards providing nutritious food to the animals are primarily promoting the Canadian market.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American Veterinary / Animal Healthcare Market profiled in this report are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health Inc., Merck & Co Inc., and Protein Sciences.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                

                                                5.1.1.1 Bovine                                   

                                                5.1.1.2 Porcine                                 

                                                5.1.1.3 Ovine                                     

                                                5.1.1.4 Poultry                                  

                                                5.1.1.5 Equine                                   

                                5.1.2 Companion vaccines                                                           

                                                5.1.2.1 Canine                                   

                                                5.1.2.2 Feline                                    

                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 United States                                                                            

                6.3 Canada                                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, Collaborations, and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Veterinary Vaccines Market By Region, From 2021 to 2026 (USD Million)
  2. North America Veterinary Vaccines Market By Type, From 2021 to 2026 (USD Million)
  3. North America Livestock vaccines Market By Region, From 2019-2024( USD Billion )
  4. North America Companion vaccines Market By Region, From 2021 to 2026 (USD Million)
  5. North America Veterinary Vaccines Market By Technology, From 2021 to 2026 (USD Million)
  6. North America Live attenuated vaccines Market By Region, From 2021 to 2026 (USD Million)
  7. North America Inactivated vaccines Market By Region, From 2021 to 2026 (USD Million)
  8. North America Recombinant vaccines Market By Region, From 2021 to 2026 (USD Million)
  9. North America Toxoid vaccines Market By Region, From 2021 to 2026 (USD Million)
  10. North America Subunit vaccines Market By Region, From 2021 to 2026 (USD Million)
  11. North America DNA vaccines Market By Region, From 2021 to 2026 (USD Million)
  12. North America Conjugate vaccines Market By Region, From 2021 to 2026 (USD Million)
  13. North America Livestock Vaccines Market By Type, From 2021 to 2026 (USD Million)
  14. North America Bovine Market By Region, From 2021 to 2026 (USD Million)
  15. North America porcine Market By Region, From 2021 to 2026 (USD Million)
  16. North America Ovine Market By Region, From 2021 to 2026 (USD Million)
  17. North America Poultry Market By Region, From 2021 to 2026 (USD Million)
  18. North America Equine Market By Region, From 2021 to 2026 (USD Million)
  19. North America Companion Animal Vaccines Market By Type, From 2021 to 2026 (USD Million)
  20. North America canine Market By Region, From 2021 to 2026 (USD Million)
  21. North America feline Market By Region, From 2021 to 2026 (USD Million)
  22. United States Veterinary Vaccines Market By Type, From 2019-2024   ( USD Billion )
  23. United States Veterinary Vaccines Market By Technology, From 2021 to 2026 (USD Million)
  24. Canada Veterinary Vaccines Market By Type, From 2021 to 2026 (USD Million)
  25. Canada Veterinary Vaccines Market By Technology, From 2021 to 2026 (USD Million)
  26. United States Livestock Vaccines Market By Type, From 2021 to 2026 (USD Million)
  27. Canada Livestock Vaccines Market By Type, From 2021 to 2026 (USD Million)
  28. United States Companion Animal Vaccines Market By Type, From 2021 to 2026 (USD Million)
  29. Canada Companion Animal Vaccines Market By Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample